Literature DB >> 1825446

Transient anticardiolipin antibodies, functional protein S deficiency, and deep vein thrombosis.

Z M Sthoeger1, D Sthoeger, S D Mellnick, D Steen, A Berrebi.   

Abstract

A 30-year-old man presented with an episode of deep vein thrombosis. He was found to have primary antiphospholipid syndrome with anticardiolipin antibodies and protein S deficiency. All other investigations were negative. Three months later, anticardiolipin antibodies were negative and protein S levels were normal. The transient presence of anticardiolipin antibodies and functional protein S deficiency in this patient suggests a new mechanism for the association between anticardiolipin antibodies and venous thrombosis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1825446     DOI: 10.1002/ajh.2830360309

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  6 in total

Review 1.  Clinical trials for the antiphospholipid syndrome.

Authors:  J T Merrill
Journal:  Curr Rheumatol Rep       Date:  2000-06       Impact factor: 4.592

Review 2.  The antiphospholipid syndrome and atherosclerosis: clue to pathogenesis.

Authors:  Joan T Merrill
Journal:  Curr Rheumatol Rep       Date:  2003-10       Impact factor: 4.592

Review 3.  What causes the antiphospholipid syndrome?

Authors:  J T Merrill
Journal:  Curr Rheumatol Rep       Date:  2001-08       Impact factor: 4.592

4.  Reduced free protein S levels in patients with inflammatory bowel disease: prevalence, clinical relevance, and role of anti-protein S antibodies.

Authors:  S Saibeni; M Vecchi; C Valsecchi; E M Faioni; C Razzari; R de Franchis
Journal:  Dig Dis Sci       Date:  2001-03       Impact factor: 3.199

5.  Antiphospholipid syndrome presenting as pulmonary thrombosis and pancreatitis in a young man.

Authors:  Sanat Phatak; Neelam Redkar; Meenakshi Amit Patil; Niteen D Karnik
Journal:  BMJ Case Rep       Date:  2012-12-12

6.  Antiphospholipid antibodies in vascular surgery patients. A cross-sectional study.

Authors:  L M Taylor; R W Chitwood; R L Dalman; G Sexton; S H Goodnight; J M Porter
Journal:  Ann Surg       Date:  1994-10       Impact factor: 12.969

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.